J7677 Revefenacin inh non-com 1mcg

Revefenacin inhalation solution, fda-approved final product, non-compounded, administered through dme, 1 microgram

• Medicare coverage: Carrier judgment
• Status: active (July 2026 file)
• MUE: max 175 units per day (practitioner), rationale: Prescribing Information